Designing a National Education Program to support quality use of medicines in Inflammatory Bowel Disease


The program aims to achieve better patient health outcomes, support optimal use of biological and small molecule medicines and contribute to Pharmaceutical Benefits Scheme sustainability across a range of specialty areas including gastroenterology, rheumatology and dermatology.

Presented at GESA AGW 2021

Download resource

Download (961.79 KB, PDF)

Published date

4 September 2021

Resource type


Governance topic

Evidence into practice